Fred Telling - Mar 30, 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Stock symbol: OGEN
Transactions as of: Mar 30, 2022
Transactions value $: $66,053
Form type: 4
Date filed: 4/1/2022, 04:05 PM
Previous filing: Dec 17, 2021
Next filing: May 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGEN	Common Stock	Purchase	$45.3K	+125K	+20.93%	$0.36	721K	Mar 30, 2022	Direct	F1
transaction	OGEN	Common Stock	Purchase	$20.8K	+59.1K	+8.19%	$0.35	780K	Mar 31, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Content

The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.